1. Home
  2. SBET vs DMRA Comparison

SBET vs DMRA Comparison

Compare SBET & DMRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SharpLink Gaming Ltd.

SBET

SharpLink Gaming Ltd.

N/A

Current Price

$5.49

Market Cap

1.5B

Sector

Technology

ML Signal

N/A

DMRA

Damora Therapeutics Inc. Common Stock

N/A

Current Price

$21.10

Market Cap

1.5B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SBET
DMRA
Founded
1995
2011
Country
United States
United States
Employees
N/A
7
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.5B
IPO Year
2025
2020

Fundamental Metrics

Financial Performance
Metric
SBET
DMRA
Price
$5.49
$21.10
Analyst Decision
Strong Buy
Buy
Analyst Count
7
2
Target Price
$18.71
$43.00
AVG Volume (30 Days)
7.3M
300.4K
Earning Date
05-11-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$28,055,000.00
N/A
Revenue This Year
$105.19
N/A
Revenue Next Year
$13.53
N/A
P/E Ratio
N/A
N/A
Revenue Growth
666.04
N/A
52 Week Low
$5.06
$16.50
52 Week High
$49.52
$28.76

Technical Indicators

Market Signals
Indicator
SBET
DMRA
Relative Strength Index (RSI) 36.33 31.57
Support Level N/A $16.50
Resistance Level $8.20 $26.66
Average True Range (ATR) 0.36 1.63
MACD -0.09 -0.42
Stochastic Oscillator 27.81 12.21

Price Performance

Historical Comparison
SBET
DMRA

About SBET SharpLink Gaming Ltd.

SharpLink Inc is one of those publicly traded companies to adopt ETH as its primary treasury reserve asset. This move reflects the Company's commitment to align corporate treasury with the future of programmable finance, digital capital markets, and decentralized infrastructure. The Company also operates an online affiliate marketing company that delivers different fan activation solutions to its sportsbook and online casino gaming partners. The company operates in two reportable segments: ETH Treasury Management and Affiliate Marketing. The majority of its revenue is generated from the ETH Treasury Management. Geographically, the company operates in the United States and the rest of the world.

About DMRA Damora Therapeutics Inc. Common Stock

Damora Therapeutics Inc is a biotechnology company that aims to fundamentally redefine care for people with hematologic disorders. The group is advancing a new generation of biologics to treat mutant calreticulin-driven myeloproliferative neoplasms, including essential thrombocythemia and myelofibrosis, where there is cruicial medical need for disease-modifying treatments. Its goal is to rapidly bring forward optimized therapies with broad mutation coverage and exceptional convenience to dramatically improve patient outcomes. The group's pipeline products are DMR-001, DMR-002, DMR-003, and GB3226.

Share on Social Networks: